Co-diagnostics, inc. to participate in yale university salivadirect™ conference held july 28-29 in chicago

Salt lake city , july 27, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) ("co-dx" or the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be attending and speaking at the yale school of public health salivadirect™ conference held july 28-29 in chicago, il. the mission of yale's salivadirect is to advance the use of saliva-based testing as a readily-deployable, sensitive, patient-friendly option that increases access to affordable and equitable infectious disease testing.
CODX Ratings Summary
CODX Quant Ranking